MX9202982A - Derivados de los acidos quinolon - y naftiridon - carboxilicos, procedimiento para su obtencion y medicamentos que los contienen. - Google Patents
Derivados de los acidos quinolon - y naftiridon - carboxilicos, procedimiento para su obtencion y medicamentos que los contienen.Info
- Publication number
- MX9202982A MX9202982A MX9202982A MX9202982A MX9202982A MX 9202982 A MX9202982 A MX 9202982A MX 9202982 A MX9202982 A MX 9202982A MX 9202982 A MX9202982 A MX 9202982A MX 9202982 A MX9202982 A MX 9202982A
- Authority
- MX
- Mexico
- Prior art keywords
- naftiridon
- quinolon
- carboxylics
- medicines
- derivatives
- Prior art date
Links
- GSDSWSVVBLHKDQ-UHFFFAOYSA-N 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid Chemical compound FC1=CC(C(C(C(O)=O)=C2)=O)=C3N2C(C)COC3=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-UHFFFAOYSA-N 0.000 title 1
- 239000002253 acid Substances 0.000 title 1
- 150000007513 acids Chemical class 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4120646A DE4120646A1 (de) | 1991-06-22 | 1991-06-22 | 7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9202982A true MX9202982A (es) | 1992-12-01 |
Family
ID=6434522
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9202982A MX9202982A (es) | 1991-06-22 | 1992-06-18 | Derivados de los acidos quinolon - y naftiridon - carboxilicos, procedimiento para su obtencion y medicamentos que los contienen. |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5464796A (OSRAM) |
| EP (1) | EP0520240A1 (OSRAM) |
| JP (1) | JPH05239051A (OSRAM) |
| KR (1) | KR930000503A (OSRAM) |
| CN (1) | CN1068115A (OSRAM) |
| AU (1) | AU648669B2 (OSRAM) |
| CA (1) | CA2071677A1 (OSRAM) |
| CZ (1) | CZ190192A3 (OSRAM) |
| DE (1) | DE4120646A1 (OSRAM) |
| FI (1) | FI922873A7 (OSRAM) |
| HU (1) | HUT62288A (OSRAM) |
| IE (1) | IE922003A1 (OSRAM) |
| IL (1) | IL102261A (OSRAM) |
| MX (1) | MX9202982A (OSRAM) |
| NO (1) | NO922226L (OSRAM) |
| NZ (1) | NZ243214A (OSRAM) |
| PH (1) | PH30227A (OSRAM) |
| RU (1) | RU2056411C1 (OSRAM) |
| SK (1) | SK190192A3 (OSRAM) |
| TW (1) | TW202442B (OSRAM) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4230804A1 (de) * | 1992-09-15 | 1994-03-17 | Bayer Ag | 7-Isoindolinyl-chinolon- und -naphthyridon-Derivate |
| US5527910A (en) * | 1992-12-30 | 1996-06-18 | Cheil Foods & Chemicals, Inc. | Pyridone carboxylic acid compounds and their uses for treating infectious diseases caused by bacteria |
| DE4301246A1 (de) * | 1993-01-19 | 1994-07-21 | Bayer Ag | Chinolon- und Naphthyridoncarbonsäurederivate |
| US5532239A (en) * | 1993-08-02 | 1996-07-02 | Assistance Publique - Hopitaux De Paris | Therapeutic application of fluoroquinolone derivatives |
| DE4329600A1 (de) * | 1993-09-02 | 1995-03-09 | Bayer Ag | Pyrido [1,2,3-d,e] [1,3,4] benzoxadiazinderivate |
| DE4418510A1 (de) * | 1994-05-27 | 1995-11-30 | Bayer Ag | 1,9-überbrückte Thiazolol[3,4-a]chinolinderivate |
| DE4427530A1 (de) * | 1994-08-04 | 1996-02-08 | Bayer Ag | Chinolon- und Naphthyridoncarbonsäure-Derivate |
| DE4435479A1 (de) * | 1994-10-04 | 1996-04-11 | Bayer Ag | Chinolon- und Naphthyridoncarbonsäure-Derivate |
| DE19500792A1 (de) * | 1995-01-13 | 1996-07-18 | Bayer Ag | Chinolon- und Naphthyridoncarbonsäure-Derivate |
| JPH08213881A (ja) * | 1995-02-02 | 1996-08-20 | Fujitsu Ltd | 周波数制御回路 |
| DE19506535A1 (de) * | 1995-02-09 | 1996-08-14 | Bayer Ag | 1,6-Naphthyridoncarbonsäurederivate |
| DE19512484A1 (de) | 1995-04-04 | 1996-10-17 | Bayer Ag | Kohlenhydratmodifizierte Cytostatika |
| NZ503740A (en) * | 1997-09-15 | 2002-09-27 | Procter & Gamble | Antimicrobial quinolones, their compositions and uses |
| PA8466701A1 (es) | 1998-01-21 | 2000-09-29 | Pfizer Prod Inc | Comprimido de mesilato de trovafloxacino |
| SE9801474D0 (sv) * | 1998-04-27 | 1998-04-27 | Active Biotech Ab | Quinoline Derivatives |
| SE9802549D0 (sv) * | 1998-07-15 | 1998-07-15 | Active Biotech Ab | Quinoline derivatives |
| SE9802550D0 (sv) * | 1998-07-15 | 1998-07-15 | Active Biotech Ab | Quinoline derivatives |
| RU2248970C2 (ru) * | 1998-11-24 | 2005-03-27 | Дайити Фармасьютикал Ко., Лтд. | Циклоалкилзамещенные производные аминометилпирролидина и антибактериальный агент на их основе |
| DE19854357A1 (de) * | 1998-11-25 | 2000-05-31 | Bayer Ag | Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure |
| RU2299205C2 (ru) * | 2000-02-09 | 2007-05-20 | Дайити Фармасьютикал Ко., Лтд. | Средство против кислотоустойчивых бактерий, содержащее пиридонкарбоновые кислоты в качестве активного компонента |
| BR0110290A (pt) * | 2000-04-24 | 2003-02-18 | Daiichi Seiyaku Co | Preparação lìquida estabilizada |
| US7220824B1 (en) | 2000-08-28 | 2007-05-22 | Bayer Aktiengesellschaft | Integrin-mediated drug targeting |
| EP1219634A1 (en) * | 2000-12-27 | 2002-07-03 | Bayer Aktiengesellschaft | Cytostatic-glycoconjugates having specifically cleavable peptidic linking units |
| JP2004528298A (ja) * | 2001-02-21 | 2004-09-16 | ツェンタリス ゲゼルシャフト ミット ベシュレンクテル ハフツング | ゴナドトロピン放出ホルモンのアンタゴニストとしてのキノリン、イソキノリン及びフタラジン誘導体 |
| EP1238678A1 (en) * | 2001-03-08 | 2002-09-11 | Bayer Aktiengesellschaft | Enzyme-activated cytostatic conjugates with integrin ligands |
| RU2275361C3 (ru) * | 2002-11-20 | 2021-10-01 | Джапан Тобакко Инк. | Соединение 4-оксохинолина и его применение в качестве ингибитора вич интегразы |
| SI1937642T1 (sl) * | 2005-10-19 | 2015-01-30 | Teva Pharmaceutical Industries Ltd. | Kristali natrijevega lakvinimoda in postopek za njihovo pripravo |
| US20070197548A1 (en) | 2006-02-17 | 2007-08-23 | Murthy Yerramilli V S | Fluoroquinolone compositions |
| US20070196398A1 (en) * | 2006-02-17 | 2007-08-23 | Murthy Yerramilli V S | Fluoroquinolone fatty acid salt compositions |
| US7973022B2 (en) | 2006-02-17 | 2011-07-05 | Idexx Laboratories, Inc. | Fluoroquinolone carboxylic acid salt compositions |
| EP1999125A2 (en) * | 2006-03-28 | 2008-12-10 | The Procter and Gamble Company | A coupling process for preparing quinolone intermediates |
| NZ570494A (en) * | 2006-03-28 | 2011-09-30 | Warner Chilcott Co Llc | Malate salts, and polymorphs of (3S,5S)-7-[3-amino-5-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid |
| RU2399616C1 (ru) * | 2006-06-23 | 2010-09-20 | Джапан Тобакко Инк. | Производное 6-(гетероциклзамещенный бензил)-4-оксохинолина и его применение в качестве ингибитора интегразы вич |
| KR100690084B1 (ko) * | 2006-11-01 | 2007-03-09 | 주식회사 세홍이엔씨 | 출입문과 연동하는 주택 내 배전반 |
| USD612227S1 (en) | 2009-02-06 | 2010-03-23 | Rockler Companies, Inc. | Workpiece finishing support |
| WO2013111158A2 (en) * | 2012-01-03 | 2013-08-01 | Msn Laboratories Limited | Process for the preparation of dpp-iv inhibitor |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5746986A (en) * | 1980-09-02 | 1982-03-17 | Dai Ichi Seiyaku Co Ltd | Pyrido(1,2,3-de)(1,4)benzoxazine derivative |
| NZ208470A (en) * | 1983-07-18 | 1988-06-30 | Abbott Lab | 6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid derivatives and antibacterial compositions containing such |
| NZ210847A (en) * | 1984-01-26 | 1988-02-29 | Abbott Lab | Naphthyridine and pyridopyrimidine derivatives and pharmaceutical compositions |
| DE3577089D1 (de) * | 1984-01-26 | 1990-05-17 | Abbott Lab | Antibakterielle chinolinderivate. |
| DE3420743A1 (de) * | 1984-06-04 | 1985-12-05 | Bayer Ag, 5090 Leverkusen | 7-amino-1-cyclopropyl-6,8-dihalogen-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel |
| GB8612137D0 (en) * | 1986-05-19 | 1986-06-25 | Fujisawa Pharmaceutical Co | Quinolone compounds |
| JPH0262875A (ja) * | 1988-05-23 | 1990-03-02 | Wakunaga Pharmaceut Co Ltd | 新規イソインドリン誘導体 |
| JP2844079B2 (ja) * | 1988-05-23 | 1999-01-06 | 塩野義製薬株式会社 | ピリドンカルボン酸系抗菌剤 |
| DE3906365A1 (de) * | 1988-07-15 | 1990-01-18 | Bayer Ag | 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe |
| DE3910663A1 (de) * | 1989-04-03 | 1990-10-04 | Bayer Ag | 5-alkylchinoloncarbonsaeuren |
| JPH04504852A (ja) * | 1989-04-26 | 1992-08-27 | ジ・アップジョン・カンパニー | 抗菌性ピリド（１，２，３―デ）―１，４―ベンゾオキサジノン剤 |
| CA2030217A1 (en) * | 1989-11-21 | 1991-05-22 | Jun Imose | Pyridone-carboxylic acid derivatives useful as veterinary medicines |
-
1991
- 1991-06-22 DE DE4120646A patent/DE4120646A1/de not_active Withdrawn
-
1992
- 1992-05-22 TW TW081103997A patent/TW202442B/zh active
- 1992-06-03 AU AU17391/92A patent/AU648669B2/en not_active Ceased
- 1992-06-05 NO NO92922226A patent/NO922226L/no unknown
- 1992-06-10 EP EP92109742A patent/EP0520240A1/de not_active Withdrawn
- 1992-06-11 US US07/896,955 patent/US5464796A/en not_active Expired - Fee Related
- 1992-06-17 PH PH44526A patent/PH30227A/en unknown
- 1992-06-18 FI FI922873A patent/FI922873A7/fi unknown
- 1992-06-18 MX MX9202982A patent/MX9202982A/es unknown
- 1992-06-19 CZ CS921901A patent/CZ190192A3/cs unknown
- 1992-06-19 RU SU925052282A patent/RU2056411C1/ru active
- 1992-06-19 IL IL10226192A patent/IL102261A/en not_active IP Right Cessation
- 1992-06-19 JP JP4184679A patent/JPH05239051A/ja active Pending
- 1992-06-19 NZ NZ243214A patent/NZ243214A/en unknown
- 1992-06-19 CA CA002071677A patent/CA2071677A1/en not_active Abandoned
- 1992-06-19 SK SK1901-92A patent/SK190192A3/sk unknown
- 1992-06-20 KR KR1019920010775A patent/KR930000503A/ko not_active Withdrawn
- 1992-06-22 CN CN92104849A patent/CN1068115A/zh active Pending
- 1992-06-22 HU HU9202085A patent/HUT62288A/hu unknown
- 1992-07-01 IE IE200392A patent/IE922003A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0520240A1 (de) | 1992-12-30 |
| NZ243214A (en) | 1995-07-26 |
| NO922226D0 (no) | 1992-06-05 |
| CA2071677A1 (en) | 1992-12-23 |
| PH30227A (en) | 1997-02-05 |
| AU1739192A (en) | 1992-12-24 |
| NO922226L (no) | 1992-12-23 |
| FI922873A0 (fi) | 1992-06-18 |
| TW202442B (OSRAM) | 1993-03-21 |
| KR930000503A (ko) | 1993-01-15 |
| HUT62288A (en) | 1993-04-28 |
| CZ190192A3 (en) | 1993-01-13 |
| RU2056411C1 (ru) | 1996-03-20 |
| FI922873A7 (fi) | 1992-12-23 |
| JPH05239051A (ja) | 1993-09-17 |
| AU648669B2 (en) | 1994-04-28 |
| CN1068115A (zh) | 1993-01-20 |
| IL102261A0 (en) | 1993-01-14 |
| IE922003A1 (en) | 1992-12-30 |
| US5464796A (en) | 1995-11-07 |
| HU9202085D0 (en) | 1992-09-28 |
| SK190192A3 (en) | 1995-08-09 |
| IL102261A (en) | 1996-10-16 |
| DE4120646A1 (de) | 1992-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9202982A (es) | Derivados de los acidos quinolon - y naftiridon - carboxilicos, procedimiento para su obtencion y medicamentos que los contienen. | |
| MX9203228A (es) | Derivados de los acidos 7-aza iso indolinil-quinolon y naftiridon carboxilicos, procedimiento para su obtencion y medicamentos que los contienen. | |
| MX9205280A (es) | Derivados de benzanilida, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
| MX9202289A (es) | Nuevos derivados de tiopiranopirrol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
| MX9206306A (es) | Peptidos, procedimiento para su produccion y composicion farmaceutica que los contiene. | |
| MX9200374A (es) | Nuevos esteres esteroides, procedimiento para su preparacion y preparacion farmaceutica que los contiene. | |
| MX9206503A (es) | Nuevos derivados de lupano, proceso para su preparacion y composicion farmaceutica que los contiene. | |
| MX9202748A (es) | Compuesto de arileter, proceso para su obtencion y composicion farmaceutica que los contiene. | |
| MX9204844A (es) | Derivados de benzodioxano, procedimiento para su preparacion composiciones farmaceuticas que los contienen. | |
| MX9102500A (es) | Compuestos de bifenilio, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
| MX9201295A (es) | Derivados de benzofurano, proceso para su preparacion y composicion farmaceutica que los contienen. | |
| MX9201847A (es) | Derivados heterociclicos de antiserotoninas, procedimiento para su preparacion y medicamentos que los contienen. | |
| MX9201058A (es) | Derivados ciclicos de cetal, procedimiento para supreparacion y composicion farmaceutica que los contiene. | |
| MX9202300A (es) | Derivados de benzofurano, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
| MX9204635A (es) | Procedimiento para la preparacion de derivados de beta-fenilisoserina. | |
| MX9205132A (es) | Derivados de acidos carboxilicos heterociclicos, procedimiento para su obtencion y medicamentos que los contienen. | |
| MX9201848A (es) | Antiserotoninas, procedimiento para su preparacion y medicamentos que las contienen. | |
| MX9204395A (es) | Derivados de 3-desoxi-manosamina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
| MX9102499A (es) | Derivados de benzamida, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
| MX9207269A (es) | Bencimidazoles substituidos, proceso para su preparacion y composiciones farmaceuticas que los contienen. | |
| MX9204239A (es) | Quinolin-2-il-metoxibencilhindroxiureas, procedimiento para su preparacion y medicamentos que las contienen. | |
| MX9207070A (es) | Compuestos de benzofurano, procedimiento para su preparacion y preparado farmaceutico que los contiene. | |
| MX9204648A (es) | Nuevos derivados de esteres, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
| MX9202280A (es) | Derivados de benzofurano, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
| MX9207619A (es) | Derivados de bencenmetanamina heterocilcicamente substituida y procedimiento para su preparacion. |